Health · 3 views
FDA Slaps New Safety Warning on GLP-1 Drugs
(MedPage Today) -- The FDA is requiring manufacturers of all GLP-1 drugs to update their prescribing information to include a warning about the potential risk of non-arteritic anterior ischemic optic neuropathy (NAION), a rare but…
Summary
(MedPage Today) -- The FDA is requiring manufacturers of all GLP-1 drugs to update their prescribing information to include a warning about the potential risk of non-arteritic anterior ischemic optic neuropathy (NAION), a rare but potentially blinding
AI summaries can be wrong sometimes—always verify important details using the source article.
How AI & Automation are usedMore from Health
Continue reading recent Health coverage
- GLP-1 drugs show lower obesity-related cancer risk than insulin, but not all diabetes treatmentsContinue reading
- Very strong El Niño episodes are associated with over 100,000 additional heat-related deaths worldwide per yearContinue reading
- Heterogeneity in breast cancer linked to risk of metastasis and treatment responseContinue reading
- Was Superglue to Blame for His Lung Nodule?Continue reading
Support HappeningNow
Independent AI-powered news analysis is reader-supported. Your contribution helps cover infrastructure, summaries, and continued platform development.
Support HappeningNow